MyoKardia, Inc. was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 191.34% in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also narrowed over the past few weeks, suggesting that more solid trading could be ahead for MyoKardia. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

MyoKardia currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.  

A better-ranked stock in the Medical - Biomedical and Genetics industry is Ligand Pharmaceuticals Incorporated (LGND), which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here

Is MYOK going up? Or down? Predict to see what others think: Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaries," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>